Toxoplasmosis: the need for improved diagnostic techniques and accurate risk assessment.
D000371:Agglutination; D000818:Animals; D000906:Antibodies / Q000276:immunology; D000911:Antibodies, Monoclonal; D000953:Antigens, Protozoan / Q000032:analysis; D002371:Cat Diseases / Q000469:parasitology; D002415:Cats; D002462:Cell Membrane / Q000276:immunology; D003593:Cytoplasm / Q000276:immunology; D004797:Enzyme-Linked Immunosorbent Assay; D005455:Fluorescent Antibody Technique; D006801:Humans; D007108:Immune Tolerance; D007111:Immunity, Cellular; D007152:Immunologic Capping; D007700:Kinetics; D008565:Membrane Proteins / Q000276:immunology; D008970:Molecular Weight; D012698:Serologic Tests; D014122:Toxoplasma / Q000276:immunology*; D014123:Toxoplasmosis / Q000175:diagnosis* / Q000276:immunology; D014611:Vaccination
D000906:Antibodies; D000911:Antibodies, Monoclonal; D000953:Antigens, Protozoan; D008565:Membrane Proteins